covid/influenza single shot risks

First posted online: 6 November 2022

Once again, we MUST sound the alarm. ALL vaccines risk harm - sometimes serious, permanent or fatal. However, experimental mRNA "vaccines" are inherently even more unpredictably dangerous as they are unlike conventional vaccines.

Best described as prodrugs, human cells manufacture viral proteins in uncontrolled quantities, distributing them to unknown tissues, having an unknown final form, folded with an unknown conformation, the mRNA modified with codon optimisation and pseudouridylation.

The Pfizer/BioNTech single shot COVID-19/Influenza mRNA "vaccine" encodes the BA.4/BA.5 spike protein of SARS-CoV-2 and 4 separate versions of the haemagglutinin surface protein from strains of influenza expected to circulate this winter. It is currently in Phase I trials. (1)

Haemagglutinin (HA) is famous for binding to receptors on erythrocytes, red blood cells (RBCs), leading to formation of HA/RBC lattice complexes. This known phenomenon of RBC clumping is termed agglutination. (2) The propensity for more blood disorders goes without saying.

Given the indiscriminate distribution of mRNA-LNPs, the potential for full-length HA to bind to disparate cells via sialic acid residues and HA’s susceptibility to circulating host proteases (e.g. TMPRSS2 and HAT), the risks cannot be overstated. (3)

Incomplete mRNA-derived glycosylation could render it more pathogenic than its natural, viral counterpart. Viruses like influenza employ glycosylation, a post-translational modification, to decorate their surface viral proteins with host-cell-derived glycans (sugars).

Once again, regulators-come-enablers, compromised governments and callous pharmaceuticals are proposing mRNA "vaccines" that will bypass the innate immune system, install the genetic code of another foreign protein, and will yet further devastate our society's health.

For anyone concerned about influenza, the best course of action is simply to live as healthily as possible, strengthening the innate immune system, armed with safe and effective antivirals taken if necessary, whilst rejecting ALL vaccines (whether conventional or mRNA).

Haemagglutinin, an influenza surface protein, is known to clump erythrocytes together via lattice complexes. This may contribute to yet further blood disorders.

Glycosylation shields viral proteins from the innate immune system, but the exact mRNA-vaccinal proteins synthesised in vivo are of unknown quality, conformation and glycosylation. Unshielded vaccinal proteins may be more pathogenic.

Sources

  1. Pfizer Inc. Pfizer and BioNTech Initiate Phase 1 Study of Single Dose mRNA-Based Combination Vaccine Candidate for Influenza and COVID-19. November 3, 2022. Accessed November 6, 2022. https://www.pfizer.com/news/announcements/pfizer-and-biontech-initiate-phase-1-study-single-dose-mrna-based-combination

  2. Trombetta CM, Ulivieri C, Cox RJ, et al. Impact of erythrocyte species on assays for influenza serology. J Prev Med Hyg. 2018;59(1):E1-E7. doi:10.15167/2421-4248/jpmh2018.59.1.870

  3. Herold S, Becker C, Ridge KM, et al. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur. Respir. J. 2015;45(5):1463-1478. doi:10.1183/09031936.00186214